476 related articles for article (PubMed ID: 35204779)
1. The Role of Systemic Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction.
Weerts J; Mourmans SGJ; Barandiarán Aizpurua A; Schroen BLM; Knackstedt C; Eringa E; Houben AJHM; van Empel VPM
Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204779
[TBL] [Abstract][Full Text] [Related]
2. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
Paulus WJ; Tschöpe C
J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
[TBL] [Abstract][Full Text] [Related]
3. Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction.
Tona F; Montisci R; Iop L; Civieri G
Rev Cardiovasc Med; 2021 Mar; 22(1):97-104. PubMed ID: 33792251
[TBL] [Abstract][Full Text] [Related]
4. Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction.
Dryer K; Gajjar M; Narang N; Lee M; Paul J; Shah AP; Nathan S; Butler J; Davidson CJ; Fearon WF; Shah SJ; Blair JEA
Am J Physiol Heart Circ Physiol; 2018 May; 314(5):H1033-H1042. PubMed ID: 29424571
[TBL] [Abstract][Full Text] [Related]
5. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM
Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356
[TBL] [Abstract][Full Text] [Related]
6. Heart Failure With Preserved Ejection Fraction: Is Ischemia Due to Coronary Microvascular Dysfunction a Mechanistic Factor?
Elgendy IY; Pepine CJ
Am J Med; 2019 Jun; 132(6):692-697. PubMed ID: 30684452
[TBL] [Abstract][Full Text] [Related]
7. Heart Failure with Preserved Ejection Fraction-a Concise Review.
Adamczak DM; Oduah MT; Kiebalo T; Nartowicz S; Bęben M; Pochylski M; Ciepłucha A; Gwizdała A; Lesiak M; Straburzyńska-Migaj E
Curr Cardiol Rep; 2020 Jul; 22(9):82. PubMed ID: 32648130
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and Prognostic Significance of Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction.
Arnold JR; Kanagala P; Budgeon CA; Jerosch-Herold M; Gulsin GS; Singh A; Khan JN; Chan DCS; Squire IB; Ng LL; McCann GP
JACC Cardiovasc Imaging; 2022 Jun; 15(6):1001-1011. PubMed ID: 35033490
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in mechanistic studies of heart failure with preserved ejection fraction and its comorbidities-Role of microRNAs.
Li X; Sun M; Wang Z; Sun S; Wang Y
Eur J Clin Invest; 2024 Mar; 54(3):e14130. PubMed ID: 38071416
[TBL] [Abstract][Full Text] [Related]
10. Microvascular dysfunction in patients with heart failure with preserved ejection fraction: A meta-analysis.
Azuma M; Kato S; Fukui K; Horita N; Utsunomiya D
Microcirculation; 2023 Oct; 30(7):e12822. PubMed ID: 37491798
[TBL] [Abstract][Full Text] [Related]
11. Heart Failure with Preserved Ejection Fraction and Future Pharmacological Strategies: a Glance in the Crystal Ball.
Tschöpe C; Van Linthout S; Kherad B
Curr Cardiol Rep; 2017 Aug; 19(8):70. PubMed ID: 28656481
[TBL] [Abstract][Full Text] [Related]
12. Coronary Microvascular Dysfunction and Heart Failure with Preserved Ejection Fraction - implications for Chronic Inflammatory Mechanisms.
Fopiano KA; Jalnapurkar S; Davila AC; Arora V; Bagi Z
Curr Cardiol Rev; 2022; 18(2):e310821195986. PubMed ID: 34488616
[TBL] [Abstract][Full Text] [Related]
13. Endothelial-cell-mediated mechanism of coronary microvascular dysfunction leading to heart failure with preserved ejection fraction.
Wang Y; Zhang J; Wang Z; Wang C; Ma D
Heart Fail Rev; 2023 Jan; 28(1):169-178. PubMed ID: 35266091
[TBL] [Abstract][Full Text] [Related]
14. Coronary microvascular dysfunction and heart failure with preserved ejection fraction: what are the mechanistic links?
Sinha A; Rahman H; Perera D
Curr Opin Cardiol; 2023 Nov; 38(6):521-526. PubMed ID: 37668191
[TBL] [Abstract][Full Text] [Related]
15. Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction.
Franssen C; Chen S; Unger A; Korkmaz HI; De Keulenaer GW; Tschöpe C; Leite-Moreira AF; Musters R; Niessen HW; Linke WA; Paulus WJ; Hamdani N
JACC Heart Fail; 2016 Apr; 4(4):312-24. PubMed ID: 26682792
[TBL] [Abstract][Full Text] [Related]
16. Coronary Microcirculation in Heart Failure with Preserved Systolic Function.
Vasiljevic Z; Krljanac G; Zdravkovic M; Lasica R; Trifunovic D; Asanin M
Curr Pharm Des; 2018; 24(25):2960-2966. PubMed ID: 29992878
[TBL] [Abstract][Full Text] [Related]
17. Use of Statins in Heart Failure with Preserved Ejection Fraction: Current Evidence and Perspectives.
Ovchinnikov A; Potekhina A; Arefieva T; Filatova A; Ageev F; Belyavskiy E
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732177
[TBL] [Abstract][Full Text] [Related]
18. Reduced Myocardial Flow in Heart Failure Patients With Preserved Ejection Fraction.
Srivaratharajah K; Coutinho T; deKemp R; Liu P; Haddad H; Stadnick E; Davies RA; Chih S; Dwivedi G; Guo A; Wells GA; Bernick J; Beanlands R; Mielniczuk LM
Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27413034
[TBL] [Abstract][Full Text] [Related]
19. Advances in extracardiac mechanisms for heart failure with preserved ejection fraction.
Wang S; Xiao Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1733-1739. PubMed ID: 36748385
[TBL] [Abstract][Full Text] [Related]
20. Endothelium-dependent and independent coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction.
Yang JH; Obokata M; Reddy YNV; Redfield MM; Lerman A; Borlaug BA
Eur J Heart Fail; 2020 Mar; 22(3):432-441. PubMed ID: 31840366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
